QQ客服 官方微博 反馈留言

	Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer
	Lyu, Hui; Wang, Shuiliang; Huang, Jingcao; Wang, Bolun; He, Zhimin; Liu, Bolin*
刊名	Cancer Letters
	2018
卷号	420页码:97-108
关键词	HER3 Survivin miRNA Paclitaxel resistance Breast cancer RTKs Receptor tyrosine kinases PI-3K Phosphoinositide 3-kinase CHX Cycloheximide ELISA Enzyme-linked immunosorbent assay IHC Immunohistochemistry i.p. Intraperitoneal
ISSN号	0304-3835
DOI	10.1016/j.canlet.2018.01.065
URL标识	查看原文
WOS记录号	WOS:000428098200010
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3338810
专题	中南大学
作者单位	1.[Wang, Bolun 2.Liu, Bolin 3.Lyu, Hui] Univ Colorado, Sch Med, Dept Pathol, Anschutz Med Campus,MS 8104,12801 E 17th Ave, Aurora, CO 80045 USA.
推荐引用方式 GB/T 7714	Lyu, Hui,Wang, Shuiliang,Huang, Jingcao,et al. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer[J]. Cancer Letters,2018,420:97-108.
APA	Lyu, Hui,Wang, Shuiliang,Huang, Jingcao,Wang, Bolun,He, Zhimin,&Liu, Bolin*.(2018).Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.Cancer Letters,420,97-108.
MLA	Lyu, Hui,et al."Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer".Cancer Letters 420(2018):97-108.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。